K. Awadzi
About
In The Last Decade
K. Awadzi
56 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 73
- Infectious Diseases 1.3k
- Parasitology 711
- Ecology 710
- Health, Toxicology and Mutagenesis 525
- Small Animals 351
Countries citing papers authored by K. Awadzi
This map shows the geographic impact of K. Awadzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Awadzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Awadzi more than expected).
Fields of papers citing papers by K. Awadzi
This network shows the impact of papers produced by K. Awadzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Awadzi. The network helps show where K. Awadzi may publish in the future.
Co-authorship network of co-authors of K. Awadzi
This figure shows the co-authorship network connecting the top 25 collaborators of K. Awadzi. A scholar is included among the top collaborators of K. Awadzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Awadzi. K. Awadzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | DETERMINING THE OPTIMAL DOSE OF MOXIDECTIN FOR ONCHOCERCIASIS VIA PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELLING OF DATA FROM HEALTHY VOLUNTEERS AND PATIENTS WITH ONCHOCERCIASIS | 3 |
| 2 | 11 | |
| 3 | 169 | |
| 4 | 30 | |
| 5 | 111 | |
| 6 | 54 | |
| 7 | 2 | |
| 8 | 12 | |
| 9 | 7 | |
| 10 | 7 | |
| 11 | 39 | |
| 12 | 12 | |
| 13 | Histological studies of onchocercomata from an area with interrupted transmission in Ghana. | 7 |
| 14 | Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. | 86 |
| 15 | The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control. | 18 |
| 16 | Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis. | 24 |
| 17 | 4 | |
| 18 | 111 | |
| 19 | 33 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.